Skip to content

Impact of Hypericum ointment on perineal pain and episiotomy healing

Impact of Hypericum ointment on perineal pain and episiotomy healing

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201404085912N15
Enrollment
84
Registered
2014-04-18
Start date
2014-04-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Episiotomy. Disruption of perineal obstetric wound

Interventions

Intervention 1: The intervention group: Hypericum ointment 2 times a day for 10 days (preparation and packaging by Dineh Iran company) as much as one finger (equivalent to about 3 grams) to be applied
Treatment - Drugs
Placebo
The intervention group: Hypericum ointment 2 times a day for 10 days (preparation and packaging by Dineh Iran company) as much as one finger (equivalent to about 3 grams) to be applied topically on th
The control group: Placebo ointment 2 times a day for 10 days (preparation and packaging by Dineh Iran company) as much as one finger (equivalent to about 3 grams) to be applied topically on the site

Sponsors

Research department of Tehran University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Full term singleton pregnancy with cephalic presentation; absence of rapid or prolonged labor; absence of membranes for more than 18 hours; mediolateral episiotomy without rupture and spread with same amount of Lidocaine; lack of visible damage or defects in the perineal area; Absence of illness, addiction and drugs that influence on wound healing; Spontaneous and complete placenta outflow; Apparently healthy infant with normal weight; and Exclusion criteria: Episiotomy hematoma in the first 24 hours after childbirth; failure to use the correct and consistent command of Hypericum ointment and placebo; unwillingness to continue participating in the study; sensitivity to ointments; having sexual relation for the first 10 days of postpartum.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: 4 hours after episiotomy, 8 hours after episiotomy, 12 hours after episiotomy, 5 days after episiotomy, 10 days after episiotomy. Method of measurement: Visual Analouge Scale.;Healing of episiotomy. Timepoint: Before intervention, 5 and 10 days after episiotomy. Method of measurement: REEDA Scale of wound healing.

Secondary

MeasureTime frame
Sedative tablets counting. Timepoint: Tenth day after delivery. Method of measurement: Counted tablets.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMir Mohammad Ali Ei Mandana

Tehran University of Medical Scinces

mirmohammad@tums.ac.ir+98 21 6692 7171

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026